Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck & Co.
Biotech
Merck bags options on Evaxion's AI-designed vaccine candidates
Merck dangled more than $1 billion in milestones for options on preclinical prospects against gonorrhea and an undisclosed infectious agent.
Nick Paul Taylor
Sep 26, 2024 7:30am
2 cancer biotechs merge, creating global footprint
Sep 25, 2024 10:54am
Merck's LAG-3 combo fails colorectal cancer phase 3 study
Sep 25, 2024 8:35am
Merck, Daiichi ADC hits goal in phase 3 lung cancer study
Sep 17, 2024 7:13am
Merck, Daiichi repeat early success in small cell lung cancer
Sep 9, 2024 10:27am
Vaxcyte surges on 'stunning' 31-valent PCV win against Pfizer
Sep 3, 2024 10:32am